{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:14:17Z","timestamp":1773274457799,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Arch Occup Environ Health"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Hyperthermic intrathoracic chemotherapy (HITOC) is an additive, intraoperative treatment for selected malignant pleural tumors. To improve local tumor control, the thoracic cavity is perfused with a cisplatin-containing solution after surgical cytoreduction. Since cisplatin is probably carcinogenic to humans, potential contamination of surfaces and pathways of exposure should be systematically investigated to enable risk assessments for medical staff and thus derive specific recommendations for occupational safety.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Wipe sampling was performed at pre-selected locations during and after ten HITOC procedures, including on the surgeon's gloves, for the quantitation of surface contaminations with cisplatin. After extraction of the samples with hydrochloric acid, platinum was determined as a marker for cisplatin by voltammetry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>High median concentrations of cytostatic drugs were detected on the surgeons\u2019 (1.73\u00a0pg Cis-Pt\/cm<jats:sup>2<\/jats:sup>, IQR: 9.36\u00a0pg Cis-Pt\/cm<jats:sup>2<\/jats:sup>) and perfusionists\u2019 (0.69\u00a0pg Cis-Pt\/cm<jats:sup>2<\/jats:sup>, IQR: 1.73\u00a0pg Cis-Pt\/cm<jats:sup>2<\/jats:sup>) gloves. The display of the perfusion device showed partially elevated levels of cisplatin up to 4.92\u00a0pg Cis-Pt\/cm<jats:sup>2<\/jats:sup> and thus could represent an origin of cross-contamination. In contrast, cisplatin levels on the floor surfaces in the area of the surgeon and the perfusion device or in the endobronchial tube were relatively low.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>With a correct use of personal protective equipment and careful handling, intraoperative HITOC appears to be safe to perform with a low risk of occupational exposure to cisplatin.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00420-021-01738-3","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T09:02:55Z","timestamp":1625043775000},"page":"399-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exposure to cisplatin in the operating room during hyperthermic intrathoracic chemotherapy"],"prefix":"10.1007","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5364-6206","authenticated-orcid":false,"given":"Till","family":"Markowiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Larisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Stefan","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Rakete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"issue":"4","key":"1738_CR1","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jtcvs.2017.10.070","volume":"155","author":"MC Ambrogi","year":"2018","unstructured":"Ambrogi MC, Bertoglio P, Aprile V, Chella A, Korasidis S, Fontanini G et al (2018) Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: a 10-year experience. J Thorac Cardiovasc Surg 155(4):1857\u20131866. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.10.070","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"1738_CR2","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.ejso.2018.05.020","volume":"44","author":"P Ametsbichler","year":"2018","unstructured":"Ametsbichler P, Bohlandt A, Nowak D, Schierl R (2018) Occupational exposure to cisplatin\/oxaliplatin during pressurized intraperitoneal aerosol chemotherapy (PIPAC)? Eur J Surg Oncol 44(11):1793\u20131799. https:\/\/doi.org\/10.1016\/j.ejso.2018.05.020","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"1738_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00420-007-0181-4","volume":"80","author":"EE Brouwers","year":"2007","unstructured":"Brouwers EE, Huitema AD, Bakker EN, Douma JW, Schimmel KJ, van Weringh G et al (2007) Monitoring of platinum surface contamination in seven Dutch hospital pharmacies using inductively coupled plasma mass spectrometry. Int Arch Occup Environ Health 80(8):689\u2013699. https:\/\/doi.org\/10.1007\/s00420-007-0181-4","journal-title":"Int Arch Occup Environ Health"},{"issue":"1","key":"1738_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s1383-5718(00)00105-4","volume":"470","author":"TH Connor","year":"2000","unstructured":"Connor TH, Shults M, Fraser MP (2000) Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 degrees C using a desiccator technique. Mutat Res 470(1):85\u201392. https:\/\/doi.org\/10.1016\/s1383-5718(00)00105-4","journal-title":"Mutat Res"},{"issue":"2","key":"1738_CR5","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3892\/ijo.2012.1715","volume":"42","author":"IL Cregan","year":"2013","unstructured":"Cregan IL, Dharmarajan AM, Fox SA (2013) Mechanisms of cisplatin-induced cell death in malignant mesothelioma cells: role of inhibitor of apoptosis proteins (IAPs) and caspases. Int J Oncol 42(2):444\u2013452. https:\/\/doi.org\/10.3892\/ijo.2012.1715","journal-title":"Int J Oncol"},{"issue":"4","key":"1738_CR6","first-page":"597","volume":"40","author":"A deWerk Neal","year":"1983","unstructured":"deWerk Neal A, Wadden RA, Chiou WL (1983) Exposure of hospital workers to airborne antineoplastic agents. Am J Hosp Pharm 40(4):597\u2013601","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"1738_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1191\/1078155205jp155oa","volume":"11","author":"G Dranitsaris","year":"2005","unstructured":"Dranitsaris G, Johnston M, Poirier S, Schueller T, Milliken D, Green E et al (2005) Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract 11(2):69\u201378. https:\/\/doi.org\/10.1191\/1078155205jp155oa","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"1738_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF00405699","volume":"65","author":"AS Ensslin","year":"1994","unstructured":"Ensslin AS, Pethran A, Schierl R, Fruhmann G (1994) Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs. Int Arch Occup Environ Health 65(5):339\u2013342. https:\/\/doi.org\/10.1007\/BF00405699","journal-title":"Int Arch Occup Environ Health"},{"issue":"8128","key":"1738_CR9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/s0140-6736(79)91939-1","volume":"1","author":"K Falck","year":"1979","unstructured":"Falck K, Grohn P, Sorsa M, Vainio H, Heinonen E, Holsti LR (1979) Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1(8128):1250\u20131251. https:\/\/doi.org\/10.1016\/s0140-6736(79)91939-1","journal-title":"Lancet"},{"key":"1738_CR10","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans","author":"International Agency for Research on Cancer","year":"1999","unstructured":"International Agency for Research on Cancer (1999) IARC monographs on the evaluation of carcinogenic risks to humans. IARC Press, Geneva"},{"issue":"7","key":"1738_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/s0003-4878(00)00050-8","volume":"44","author":"H Kromhout","year":"2000","unstructured":"Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars RF, Anzion R et al (2000) Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg 44(7):551\u2013560. https:\/\/doi.org\/10.1016\/s0003-4878(00)00050-8","journal-title":"Ann Occup Hyg"},{"issue":"8","key":"1738_CR12","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/ijc.29058","volume":"137","author":"L Landeck","year":"2015","unstructured":"Landeck L, Gonzalez E, Koch OM (2015) Handling chemotherapy drugs-Do medical gloves really protect? Int J Cancer 137(8):1800\u20131805. https:\/\/doi.org\/10.1002\/ijc.29058","journal-title":"Int J Cancer"},{"key":"1738_CR13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1700883","author":"T Markowiak","year":"2019","unstructured":"Markowiak T, Neu R, Ansari MKA, Grosser C, Klinkhammer-Schalke M, Hofmann HS et al (2019) Surgical cytoreduction and HITOC for thymic malignancies with pleural dissemination. Thorac Cardiovasc Surg. https:\/\/doi.org\/10.1055\/s-0039-1700883","journal-title":"Thorac Cardiovasc Surg"},{"issue":"7","key":"1738_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/annhyg\/mei023","volume":"49","author":"HJ Mason","year":"2005","unstructured":"Mason HJ, Blair S, Sams C, Jones K, Garfitt SJ, Cuschieri MJ et al (2005) Exposure to antineoplastic drugs in two UK hospital pharmacy units. Ann Occup Hyg 49(7):603\u2013610. https:\/\/doi.org\/10.1093\/annhyg\/mei023","journal-title":"Ann Occup Hyg"},{"key":"1738_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2017.02.014","volume":"108","author":"JM Maury","year":"2017","unstructured":"Maury JM, Girard N, Tabutin M, Grima R, Chalabreysse L, Pavlakovic I et al (2017) Intra-thoracic chemo-hyperthermia for pleural recurrence of thymoma. Lung Cancer 108:1\u20136. https:\/\/doi.org\/10.1016\/j.lungcan.2017.02.014","journal-title":"Lung Cancer"},{"issue":"1","key":"1738_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00420-002-0383-8","volume":"76","author":"A Pethran","year":"2003","unstructured":"Pethran A, Schierl R, Hauff K, Grimm CH, Boos KS, Nowak D (2003) Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int Arch Occup Environ Health 76(1):5\u201310. https:\/\/doi.org\/10.1007\/s00420-002-0383-8","journal-title":"Int Arch Occup Environ Health"},{"issue":"18","key":"1738_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3238\/arztebl.2013.0313","volume":"110","author":"M Ried","year":"2013","unstructured":"Ried M, Hofmann HS (2013) The treatment of pleural carcinosis with malignant pleural effusion. Dtsch Arztebl Int 110(18):313\u2013318. https:\/\/doi.org\/10.3238\/arztebl.2013.0313","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"1738_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ejcts\/ezs418","volume":"43","author":"M Ried","year":"2013","unstructured":"Ried M, Potzger T, Braune N, Neu R, Zausig Y, Schalke B et al (2013) Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience. Eur J Cardiothorac Surg 43(4):801\u2013807. https:\/\/doi.org\/10.1093\/ejcts\/ezs418","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"1738_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/ejcts\/ezu217","volume":"47","author":"M Ried","year":"2015","unstructured":"Ried M, Lehle K, Neu R, Diez C, Bednarski P, Sziklavari Z et al (2015) Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure. Eur J Cardiothorac Surg 47(3):563\u2013566. https:\/\/doi.org\/10.1093\/ejcts\/ezu217","journal-title":"Eur J Cardiothorac Surg"},{"issue":"6","key":"1738_CR20","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/ejcts\/ezv426","volume":"49","author":"M Ried","year":"2016","unstructured":"Ried M, Marx A, Gotz A, Hamer O, Schalke B, Hofmann HS (2016) State of the art: diagnostic tools and innovative therapies for treatment of advanced thymoma and thymic carcinoma. Eur J Cardiothorac Surg 49(6):1545\u20131552. https:\/\/doi.org\/10.1093\/ejcts\/ezv426","journal-title":"Eur J Cardiothorac Surg"},{"key":"1738_CR21","doi-asserted-by":"publisher","DOI":"10.1055\/a-0573-2419","author":"M Ried","year":"2018","unstructured":"Ried M, Hofmann HS, Dienemann H, Eichhorn M (2018) Implementation of hyperthermic intrathoracic chemotherapy (HITHOC) in Germany. Zentralbl Chir. https:\/\/doi.org\/10.1055\/a-0573-2419","journal-title":"Zentralbl Chir"},{"issue":"7","key":"1738_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/annhyg\/mep050","volume":"53","author":"R Schierl","year":"2009","unstructured":"Schierl R, Bohlandt A, Nowak D (2009) Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann Occup Hyg 53(7):703\u2013711. https:\/\/doi.org\/10.1093\/annhyg\/mep050","journal-title":"Ann Occup Hyg"},{"issue":"1","key":"1738_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejso.2011.10.009","volume":"38","author":"R Schierl","year":"2012","unstructured":"Schierl R, Novotna J, Piso P, Bohlandt A, Nowak D (2012) Low surface contamination by cis\/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol 38(1):88\u201394. https:\/\/doi.org\/10.1016\/j.ejso.2011.10.009","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"1738_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/ajhp\/59.10.956","volume":"59","author":"G Schmaus","year":"2002","unstructured":"Schmaus G, Schierl R, Funck S (2002) Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm 59(10):956\u2013961. https:\/\/doi.org\/10.1093\/ajhp\/59.10.956","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"1738_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00039896.1994.9940377","volume":"49","author":"PJ Sessink","year":"1994","unstructured":"Sessink PJ, Van de Kerkhof MC, Anzion RB, Noordhoek J, Bos RP (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health 49(3):165\u2013169. https:\/\/doi.org\/10.1080\/00039896.1994.9940377","journal-title":"Arch Environ Health"},{"issue":"2","key":"1738_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jtcvs.2008.07.055","volume":"137","author":"L Zellos","year":"2009","unstructured":"Zellos L, Richards WG, Capalbo L, Jaklitsch MT, Chirieac LR, Johnson BE et al (2009) A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 137(2):453\u2013458. https:\/\/doi.org\/10.1016\/j.jtcvs.2008.07.055","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"1738_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005532","volume":"96","author":"H Zhou","year":"2017","unstructured":"Zhou H, Wu W, Tang X, Zhou J, Shen Y (2017) Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion: a systematic review and meta-analysis. Medicine (baltimore) 96(1):e5532. https:\/\/doi.org\/10.1097\/MD.0000000000005532","journal-title":"Medicine (baltimore)"}],"container-title":["International Archives of Occupational and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-021-01738-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00420-021-01738-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00420-021-01738-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T07:07:08Z","timestamp":1643267228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00420-021-01738-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1738"],"URL":"https:\/\/doi.org\/10.1007\/s00420-021-01738-3","relation":{},"ISSN":["0340-0131","1432-1246"],"issn-type":[{"value":"0340-0131","type":"print"},{"value":"1432-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"assertion":[{"value":"5 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}